• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Targeting inflammation and cytokine storm in COVID-19.

作者信息

Huang Qianwen, Wu Xiumei, Zheng Xueying, Luo Sihui, Xu Suowen, Weng Jianping

机构信息

Department of Endocrinology and Metabolism, Guangdong Provincial Key Laboratory of Diabetology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Department of Endocrinology, First Affiliated Hospital, Division of Life Sciences and Medicine, University of Science and Technology of China (USTC), Hefei, China.

出版信息

Pharmacol Res. 2020 Sep;159:105051. doi: 10.1016/j.phrs.2020.105051. Epub 2020 Jun 27.

DOI:10.1016/j.phrs.2020.105051
PMID:32603772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7320704/
Abstract
摘要

相似文献

1
Targeting inflammation and cytokine storm in COVID-19.针对新型冠状病毒肺炎中的炎症和细胞因子风暴
Pharmacol Res. 2020 Sep;159:105051. doi: 10.1016/j.phrs.2020.105051. Epub 2020 Jun 27.
2
Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19.新型冠状病毒诱导的NLRP3炎性小体激活：治疗COVID-19的潜在药物靶点
Front Immunol. 2020 May 19;11:1021. doi: 10.3389/fimmu.2020.01021. eCollection 2020.
3
Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome.直面争议：白细胞介素-6 与 COVID-19 细胞因子风暴综合征。
Eur Respir J. 2020 Oct 1;56(4). doi: 10.1183/13993003.03006-2020. Print 2020 Oct.
4
Audio Interview: Tocilizumab and Covid-19.音频访谈：托珠单抗与新冠病毒
N Engl J Med. 2020 Oct 22;383(17):e114. doi: 10.1056/NEJMe2032051.
5
Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy.将抗癌药物重新用于 COVID-19 引起的炎症、免疫功能障碍和凝血障碍。
Br J Cancer. 2020 Sep;123(5):694-697. doi: 10.1038/s41416-020-0948-x. Epub 2020 Jun 22.
6
[Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].[严重急性呼吸综合征冠状病毒2（SARS-CoV-2）：我们应该针对病毒、细胞还是疾病？]
Virologie (Montrouge). 2020 Jun 1;24(3):135-141. doi: 10.1684/vir.2020.0843.
7
Severe COVID-19: NLRP3 Inflammasome Dysregulated.严重 COVID-19：NLRP3 炎性小体失调。
Front Immunol. 2020 Jun 26;11:1580. doi: 10.3389/fimmu.2020.01580. eCollection 2020.
8
Treating COVID-19 with colchicine in community healthcare setting.在社区医疗环境中使用秋水仙碱治疗新冠病毒病
Clin Immunol. 2020 Aug;217:108490. doi: 10.1016/j.clim.2020.108490. Epub 2020 May 31.
9
The hidden role of NLRP3 inflammasome in obesity-related COVID-19 exacerbations: Lessons for drug repurposing.NLRP3 炎性小体在肥胖相关的 COVID-19 恶化中的隐藏作用：药物再利用的启示。
Br J Pharmacol. 2020 Nov;177(21):4921-4930. doi: 10.1111/bph.15229. Epub 2020 Aug 26.
10
Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome.2019冠状病毒病治疗的紧急途径：针对下游炎症以预防灾难性综合征。
Joint Bone Spine. 2020 May;87(3):191-193. doi: 10.1016/j.jbspin.2020.03.011.

引用本文的文献

1
Luteolin-Rich Extract from (Blanco) Merr. Root Alleviates SARS-CoV-2 Spike Protein-Stimulated Lung Inflammation via Inhibition of MAPK/NLRP3 Inflammasome Signaling Pathways.来自（布兰科）梅尔根特海姆氏根的富含木犀草素的提取物通过抑制丝裂原活化蛋白激酶/核苷酸结合寡聚化结构域样受体蛋白3炎性小体信号通路减轻严重急性呼吸综合征冠状病毒2刺突蛋白刺激的肺部炎症。
Life (Basel). 2025 Jul 5;15(7):1077. doi: 10.3390/life15071077.
2
A Rare Case of Small Bowel Ulceration Induced by COVID-19.一例由新冠病毒感染引起的小肠溃疡罕见病例。
J Inflamm Res. 2025 May 10;18:6123-6131. doi: 10.2147/JIR.S507209. eCollection 2025.
3
Aromatic Molecular Compatibility Attenuates Influenza Virus-Induced Acute Lung Injury via the Lung-Gut Axis and Lipid Droplet Modulation.

本文引用的文献

1
Coronavirus breakthrough: dexamethasone is first drug shown to save lives.冠状病毒研究突破：地塞米松是首个被证明能挽救生命的药物。
Nature. 2020 Jun;582(7813):469. doi: 10.1038/d41586-020-01824-5.
2
Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19.比较分析 COVID-19 重症与非重症患者的实验室指标。
Clin Chim Acta. 2020 Oct;509:180-194. doi: 10.1016/j.cca.2020.06.009. Epub 2020 Jun 6.
3
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.
芳香族分子相容性通过肺-肠轴和脂滴调节减轻流感病毒诱导的急性肺损伤。
Pharmaceuticals (Basel). 2025 Mar 26;18(4):468. doi: 10.3390/ph18040468.
4
Effects of Immunotoxicity biomarkers, essential elements and vitamin D levels on the severity levels of COVID-19 disease in Turkey.免疫毒性生物标志物、必需元素和维生素D水平对土耳其COVID-19疾病严重程度的影响。
Toxicol Res (Camb). 2024 Oct 20;13(5):tfae177. doi: 10.1093/toxres/tfae177. eCollection 2024 Oct.
5
Bioinformatic-based Study to Investigate the Structure and Function of Pro-inflammatory Cytokines TNFα and IL-6 Involved in the Pathogenesis of COVID-19.基于生物信息学的研究：探究参与新型冠状病毒肺炎发病机制的促炎细胞因子TNFα和IL-6的结构与功能
Iran J Pathol. 2024 Spring;19(2):205-217. doi: 10.30699/IJP.2024.2015557.3211. Epub 2024 Feb 15.
6
Microfluidic Immunoarray for Point-of-Care Detection of Cytokines in COVID-19 Patients.用于即时检测新冠肺炎患者细胞因子的微流控免疫阵列
ACS Omega. 2024 Jun 24;9(27):29320-29330. doi: 10.1021/acsomega.4c00735. eCollection 2024 Jul 9.
7
Potential application of mesenchymal stromal cells as a new therapeutic approach in acute respiratory distress syndrome and pulmonary fibrosis.间充质基质细胞在急性呼吸窘迫综合征和肺纤维化中的潜在应用作为一种新的治疗方法。
Respir Res. 2024 Apr 18;25(1):170. doi: 10.1186/s12931-024-02795-1.
8
Pharmacological induction of autophagy reduces inflammation in macrophages by degrading immunoproteasome subunits.药物诱导自噬通过降解免疫蛋白酶体亚基减少巨噬细胞中的炎症。
PLoS Biol. 2024 Mar 6;22(3):e3002537. doi: 10.1371/journal.pbio.3002537. eCollection 2024 Mar.
9
A Review on Role of Inflammation in Coronavirus Disease.炎症在冠状病毒病中的作用综述
Endocr Metab Immune Disord Drug Targets. 2024;24(13):1488-1505. doi: 10.2174/0118715303265274231204075802.
10
Inhibition of Polyinosinic-Polycytidylic Acid-Induced Acute Pulmonary Inflammation and NF-κB Activation in Mice by a Banana Plant Extract.香蕉植物提取物抑制多聚肌苷酸多聚胞苷酸诱导的小鼠急性肺炎症和 NF-κB 激活。
Int J Med Sci. 2024 Jan 1;21(1):107-122. doi: 10.7150/ijms.88748. eCollection 2024.
COVID-19 中的细胞因子风暴：趋化因子/趋化因子受体系统的参与概述。
Cytokine Growth Factor Rev. 2020 Jun;53:25-32. doi: 10.1016/j.cytogfr.2020.05.003. Epub 2020 May 11.
4
An Update on Current Therapeutic Drugs Treating COVID-19.治疗新型冠状病毒肺炎的当前治疗药物最新情况
Curr Pharmacol Rep. 2020;6(3):56-70. doi: 10.1007/s40495-020-00216-7. Epub 2020 May 11.
5
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.临床证据不支持使用皮质类固醇治疗2019新型冠状病毒肺炎肺损伤。
Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.
6
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.